| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 2001年天圣制药在重庆这座中国最年轻、最具活力的直辖市诞生，是国内现代化的医药科技型企业，国家高新技术企业。十六年来，天圣制药本着正气、学习、创新、进步的文化理念，扎扎实实的工作作风，精益求精态度努力去做好企业。业务范围涵盖医药制造、流通，中药材种植加工，药物研发等领域，形成了完整的产业链。 三大核心战略：天圣以制定的三大战略为引领。精品化战略，始终以质量取胜，生产精品，不偷工，不减料，尽职尽责，尽善尽美。创新型战略，不断的丰富和完善产品线和产品结构布局，拥有以小儿肺咳颗粒、延参健胃胶囊、地贞颗粒、银参通络胶囊、益气消渴颗粒、灵精胶囊等为代表的自主知识产权品种20多个，常用品种300多个，国家医保药物152个，国家基药77个，同时不断增加对新技术和高附加值产品研发的投资，目前拥有近60项专利，多项发明专利和核心专有技术应用于产品的制造过程中。人才型战略，重视人才的引进和培养，以诚信、规范，扎实的运作，引导了天圣健康、稳定、有序的向前发展。 完善的产业结构布局：天圣制药制定了“立足重庆，布局全国，仿创结合，兼收并举”的发展思路，已经在北京、四川，湖北，河北，山西，湖南等省市布局。产品涵盖了呼吸、消化、心脑血管、儿科、妇科、骨科、肿瘤、肝胆、血液、外科、糖尿病等系统。销售网络覆盖全国。 医药流通版块：天圣制药拥有以重庆长圣医药为龙头的10余家商业和物流公司。天圣药品配送体系覆盖全重庆以及四川、湖北部分区域，发展潜力巨大。还计划在重庆渝北区建设大型现代医药物流总部基地，建成后天圣的医药仓储能力、物流配送效率和信息化管理水平将大幅提升。 未来我们将坚持“以民为天，以质为圣”的发展理念，以不屈不挠的精神，不俱困难的作风，开拓创新，做好企业，以优良的业绩回报股东，以感恩之心回报社会，为国家经济社会发展尽一己之力。 | ||||||||||||||||||||||||
| Main Business | 药物研发、生产、销售、中药材种植加工。 | ||||||||||||||||||||||||
| Legal Representative | 刘爽 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 王琴 | ||||||||||||||||||||||||
| Solicitors | 北京明税律师事务所 | ||||||||||||||||||||||||
| Auditors | 北京兴华会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
| Tel No | 023-62910742 | ||||||||||||||||||||||||
| Fax No | 023-62980181 | ||||||||||||||||||||||||
| Website | www.tszy.com.cn | ||||||||||||||||||||||||
| zqb@tszy.com.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 19/05/2017 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.174 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 6.135 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.335B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |